1-5 of 5
affinity
Close
Sort by
Journal Articles

FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice

Archana Shrestha, Mengna Chi, Kimberly Wagner, Astha Malik, Jennifer Korpik, Adam Drake, Keertik Fulzele, Sylvie Guichard, Punam Malik
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2385–2390.
https://doi.org/10.1182/bloodadvances.2020003604
Published: 2021
Includes: Supplemental data
Journal Articles

Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia

Haydar Çelik, Katherine E. Lindblad, Bogdan Popescu, Gege Gui, Meghali Goswami, Janet Valdez, Christin DeStefano, Catherine Lai, Julie Thompson, Jack Y. Ghannam, Giovanna Fantoni, Angélique Biancotto, Julián Candia, Foo Cheung, Gauthaman Sukumar, Clifton L. Dalgard, Richard H. Smith, Andre Larochelle, Laura W. Dillon, Christopher S. Hourigan
Journal: Blood Advances
Blood Adv (2020) 4 (2): 367–379.
https://doi.org/10.1182/bloodadvances.2019001124
Published: 2020
Includes: Supplemental data
Journal Articles

Rap1 binding to the talin 1 F0 domain makes a minimal contribution to murine platelet GPIIb-IIIa activation

Frederic Lagarrigue, Alexandre R. Gingras, David S. Paul, Andrew J. Valadez, Monica N. Cuevas, Hao Sun, Miguel A. Lopez-Ramirez, Benjamin T. Goult, Sanford J. Shattil, Wolfgang Bergmeier, Mark H. Ginsberg
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2358–2368.
https://doi.org/10.1182/bloodadvances.2018020487
Published: 2018
Includes: Supplemental data
Journal Articles

Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens

Jefferson L. Lansford, Udara Dharmasiri, Shengjie Chai, Sally A. Hunsucker, Dante S. Bortone, James E. Keating, Ian M. Schlup, Gary L. Glish, Edward J. Collins, Gheath Alatrash, Jeffrey J. Molldrem, Paul M. Armistead, Benjamin G. Vincent
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2052–2062.
https://doi.org/10.1182/bloodadvances.2018022475
Published: 2018
Includes: Supplemental data
Journal Articles

FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity

Ruth A. Ettinger, Joseph A. Liberman, Devi Gunasekera, Komal Puranik, Eddie A. James, Arthur R. Thompson, Kathleen P. Pratt
Journal: Blood Advances
Blood Adv (2018) 2 (4): 309–322.
https://doi.org/10.1182/bloodadvances.2017013482
Published: 2018
Includes: Supplemental data